﻿               SEQUENCE LISTING

<110> GENETHON
      UNIVERSITY OF LEICESTER
      INSTITUT NATIONAL DE LA RECHERCHE ET DE LA SANTE MEDICALE
      UNIVERSITE EVRY VAL D’ESSONNE

<120> Peptide that binds to an AAV capsid

<130> 1H274440_CAS 2

<160> 12

<170> BiSSAP 1.3.6

<210> 1
<211> 15
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide 1 without linker

<400> 1
Leu Ser Val Ser Pro Gly Gly Gln Trp Leu Val Ser Gly Ser Asp 
1               5                   10                  15  

<210> 2
<211> 17
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide 2 without linker

<400> 2
His Leu Ser Gln Gly Val Gln Trp Ser Leu Leu Leu Ala Val Pro Ser 
1               5                   10                  15      
Arg 
    

<210> 3
<211> 18
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide 3 without linker

<400> 3
Thr Val Gly Phe Gly Gly Ile Gly Ser Leu Ile Asp Phe Ile Leu Ile 
1               5                   10                  15      
Ser Arg 
        

<210> 4
<211> 19
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide 4 without linker

<400> 4
Gln Ile Val Gly Pro Ser Asp Gly Ser Ser Tyr Ile Ile Asp Tyr Tyr 
1               5                   10                  15      
Gly Thr Arg 
            

<210> 5
<211> 26
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide 5 without linker

<400> 5
Leu Thr Ser Pro Gln Val Tyr Asp Asn Gln Glu Pro Leu Arg Glu Glu 
1               5                   10                  15      
Asp Ser Asp Phe Ile Leu Thr Glu Gly Asp 
            20                  25      

<210> 6
<211> 29
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide 6 without linker

<400> 6
Leu Thr Leu Thr Tyr Gly Asp Ser Thr Val Thr Ala Asn Gly Ser Ser 
1               5                   10                  15      
Ser Ser His Thr Ala Ser Thr Ser Leu Glu Gly Ser Arg 
            20                  25                  

<210> 7
<211> 16
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide 1 with linker

<400> 7
Cys Leu Ser Val Ser Pro Gly Gly Gln Trp Leu Val Ser Gly Ser Asp 
1               5                   10                  15      



<210> 8
<211> 19
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide 2 with linker

<400> 8
Cys Gly His Leu Ser Gln Gly Val Gln Trp Ser Leu Leu Leu Ala Val 
1               5                   10                  15      
Pro Ser Arg 
            

<210> 9
<211> 20
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide 3 with linker

<400> 9
Cys Gly Thr Val Gly Phe Gly Gly Ile Gly Ser Leu Ile Asp Phe Ile 
1               5                   10                  15      
Leu Ile Ser Arg 
            20  

<210> 10
<211> 20
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide 4 with linker

<400> 10
Cys Gln Ile Val Gly Pro Ser Asp Gly Ser Ser Tyr Ile Ile Asp Tyr 
1               5                   10                  15      
Tyr Gly Thr Arg 
            20  

<210> 11
<211> 28
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide 5 with linker

<400> 11
Cys Gly Leu Thr Ser Pro Gln Val Tyr Asp Asn Gln Glu Pro Leu Arg 
1               5                   10                  15      
Glu Glu Asp Ser Asp Phe Ile Leu Thr Glu Gly Asp 
            20                  25              

<210> 12
<211> 30
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide 6 with linker

<400> 12
Cys Leu Thr Leu Thr Tyr Gly Asp Ser Thr Val Thr Ala Asn Gly Ser 
1               5                   10                  15      
Ser Ser Ser His Thr Ala Ser Thr Ser Leu Glu Gly Ser Arg 
            20                  25                  30  

